Scientific Industries, Inc.
                 70 Orville Drive
             Bohemia, New York 11716 USA


FOR IMMEDIATE RELEASE (Bohemia, NY, September 30, 2008)

Scientific Industries Reports Increased Earnings for Fiscal 2008
and a Cash Dividend


Scientific Industries Inc. (OTCBB-SCND), September 30, 2008 -
Scientific Industries Inc. reported on Monday, September 29, 2008,
that for the year ended June 30, 2008 net income was $391,500
($0.34 per basic share), an increase of $79,500 (25.5%), and net
sales were $6,669,400, an increase of $1,789,000 (36.7%) as
compared with results for the year ended June 30, 2007.   For
fiscal 2007, net income was $312,000 ($0.29 per basic share) on
net sales of $4,880,000.

The addition since November 30, 2006, the date it was acquired,
of the new catalyst research instruments operations, which
incurred a loss in fiscal 2007, was responsible for the
increase in net income and, along with a 6% increase in net
sales of its benchtop laboratory equipment, for the increased
net sales.

The Company's Board of Directors declared a cash dividend of
$.08 per share of Common Stock payable on January 16, 2009 to
holders of record as of the close of business on October 27, 2008.

Ms. Helena R. Santos, President and Chief Executive Officer,
stated that while the results for the first quarter of the
current fiscal year have been adversely affected primarily
by supplier-caused delays in the fulfillment of some of its
research instrument orders and despite current economic
challenges, she remains optimistic about the results for
the full fiscal year.  In this respect she noted that order
backlog as of June 30, 2008 was approximately $771,000.


About Scientific Industries
Scientific Industries designs, manufactures, and markets a
variety of laboratory equipment, including the world-
renowned Vortex-Genie? 2 Mixer, and since November 2006
produces and sells customized catalyst research
instruments. Scientific Industries' products are generally
used for research purposes in laboratories of universities,
hospitals, pharmaceutical companies, chemical companies,
and medical device manufacturers.

"Statements made in this press release that relate to future
events, performance or financial results of the Company are
forward-looking statements which involve uncertainties that
could cause actual events, performance or results to materially
differ. The Company undertakes no obligation to update any
of these statements. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak
only as to the date hereof. Accordingly, any forward-looking
statement should be read in conjunction with the additional
information about risks and uncertainties set forth in the
Company's Securities and Exchange Commission reports,
including our annual report on Form 10-KSB."


                    ###